Scotland's life sciences strategy is a welcome vision that must be matched with delivery, says ABPI
The Strategy aims to create the most effective environment for developing, testing, manufacturing and commercialising life sciences innovation.
Read the full articleYou might also wanna read
Scotland Unveils National AI Strategy to Drive Growth, Skills, and Responsible Innovation Through 2031
Scotland has unveiled a sweeping national artificial intelligence strategy aimed at driving economic growth, strengthening public services a
UK Life Sciences Must Move From Innovation Pilots to National Adoption
The UK is not short of innovation. The challenge is building the national systems, funding routes and procurement models needed to turn prom
In Vivo, a resource for life sciences business strategy, is now available
In Vivo, from Informa Pharma Intelligence, covers the biopharma, medtech, and diagnostics industries and is a useful resource for life scien
Rakesh Uppal comments on London Life Sciences Strategy
Writing for Healthcare Today, Rakesh Uppal, chief executive of Barts Life Sciences, says that an ambitious life sciences strategy for London
Navigating the Complex Landscape of Cell and Gene Therapy Manufacturing
Consultants from ProPharma express optimism about the trajectory of cell and gene therapy despite technical and logistical difficulties rema
Biosimilar Success in an Evolving Landscape: Development Considerations for Staying Competitive
Evolution beyond traditional monoclonal antibodies and regulatory shifts are creating challenging conditions for biosimilars development. Ho
Comments
Sign in to join the conversation.
No comments yet. Be the first.